FDA warning letter targets doctor who worked on a Takeda Phase 3 study

Back in January, Takeda won approval for a new indication for its primary immunodeficiency drug HyQvia, this time as a treatment for a rare autoimmune …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

F. Hoffmann-La Roche sees highest filings and grants during August in Q3 2023

Share this article F. Hoffmann-La Roche has been focused on protecting inventions in United States(US) with 333 publications in Q3 2023 The United States(US) Patent

November 24, 2023

‘Shambolic’ Medical Meeting; DaVita Whistleblower Suit; FDA Mum on MDMA

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. A ‘Shambolic’ Medical Conference A Nature

July 25, 2024

Apollo secures funds to advance pipeline programmes

Share this article Since its founding, Apollo Therapeutics secured total funds of more than $450m. Credit: Gorodenkoff / Shutterstock.com. Apollo Therapeutics has secured $33.5m in

January 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.